Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
85
20
23
20
20
21
Revenue Growth (YoY)
-7%
-5%
-4%
-5%
-13%
-13%
Cost of Revenue
35
8
9
8
8
9
Gross Profit
49
12
14
12
11
12
Selling, General & Admin
36
10
9
8
8
10
Research & Development
8
2
2
2
2
2
Operating Expenses
49
13
12
11
12
13
Other Non Operating Income (Expenses)
-2
0
-1
0
0
0
Pretax Income
-9
-3
-3
-1
-2
-50
Income Tax Expense
0
0
0
0
0
0
Net Income
-9
-3
-2
-1
-2
-50
Net Income Growth
-84%
-94%
--
-75%
0%
1,150%
Shares Outstanding (Diluted)
4.47
4.47
4.46
4.45
4.43
4.4
Shares Change (YoY)
1%
1%
2%
2%
2%
2%
EPS (Diluted)
-2.19
-0.76
-0.63
-0.27
-0.51
-11.41
EPS Growth
-83%
-93%
-159,675%
-75%
-23%
956%
Free Cash Flow
1
-1
0
0
2
2
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
57.64%
60%
60.86%
60%
55%
57.14%
Operating Margin
0%
0%
4.34%
0%
0%
-4.76%
Profit Margin
-10.58%
-15%
-8.69%
-5%
-10%
-238.09%
Free Cash Flow Margin
1.17%
-5%
0%
0%
10%
9.52%
EBITDA
3
0
1
0
1
0
EBITDA Margin
3.52%
0%
4.34%
0%
5%
0%
D&A For EBITDA
3
0
0
0
1
1
EBIT
0
0
1
0
0
-1
EBIT Margin
0%
0%
4.34%
0%
0%
-4.76%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are UAV Corp's key financial statements?
According to the latest financial statement (Form-10K), Harvard Bioscience Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for UMAV?
Harvard Bioscience Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is UAV Corp's revenue broken down by segment or geography?
Harvard Bioscience Inc largest revenue segment is Instruments, Equipment, Software and Accessories, at a revenue of 78,260,000 in the most earnings release.For geography, United States is the primary market for Harvard Bioscience Inc, at a revenue of 38,966,000.
Is UAV Corp profitable?
no, according to the latest financial statements, Harvard Bioscience Inc has a net loss of $0
Does UAV Corp have any liabilities?
no, Harvard Bioscience Inc has liability of 0
How many outstanding shares for UAV Corp?
Harvard Bioscience Inc has a total outstanding shares of 0